HNSPF
Price
$4.04
Change
+$0.49 (+13.84%)
Updated
Jul 2 closing price
Capitalization
9.59B
TSMRF
Price
$23.74
Change
-$4.41 (-15.67%)
Updated
Jun 27 closing price
Capitalization
1.44B
Interact to see
Advertisement

HNSPF vs TSMRF

Header iconHNSPF vs TSMRF Comparison
Open Charts HNSPF vs TSMRFBanner chart's image
Hansoh Pharmaceutical Group
Price$4.04
Change+$0.49 (+13.84%)
Volume$1K
Capitalization9.59B
Tsumura & Co
Price$23.74
Change-$4.41 (-15.67%)
Volume$100
Capitalization1.44B
HNSPF vs TSMRF Comparison Chart in %
Loading...
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HNSPF vs. TSMRF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNSPF is a Hold and TSMRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (HNSPF: $4.03 vs. TSMRF: $23.74)
Brand notoriety: HNSPF and TSMRF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HNSPF: 18% vs. TSMRF: 100%
Market capitalization -- HNSPF: $9.59B vs. TSMRF: $1.44B
HNSPF [@Pharmaceuticals: Other] is valued at $9.59B. TSMRF’s [@Pharmaceuticals: Other] market capitalization is $1.44B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HNSPF’s FA Score shows that 2 FA rating(s) are green whileTSMRF’s FA Score has 2 green FA rating(s).

  • HNSPF’s FA Score: 2 green, 3 red.
  • TSMRF’s FA Score: 2 green, 3 red.
According to our system of comparison, HNSPF is a better buy in the long-term than TSMRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HNSPF’s TA Score shows that 5 TA indicator(s) are bullish.

  • HNSPF’s TA Score: 5 bullish, 0 bearish.

Price Growth

HNSPF (@Pharmaceuticals: Other) experienced а +13.86% price change this week, while TSMRF (@Pharmaceuticals: Other) price change was -15.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSPF($9.59B) has a higher market cap than TSMRF($1.44B). HNSPF has higher P/E ratio than TSMRF: HNSPF (30.21) vs TSMRF (12.64). HNSPF YTD gains are higher at: 89.152 vs. TSMRF (-15.672). TSMRF has higher annual earnings (EBITDA): 37B vs. HNSPF (3.62B). TSMRF has more cash in the bank: 93.7B vs. HNSPF (20.9B). HNSPF has less debt than TSMRF: HNSPF (4.13B) vs TSMRF (79.7B). TSMRF has higher revenues than HNSPF: TSMRF (138B) vs HNSPF (9.97B).
HNSPFTSMRFHNSPF / TSMRF
Capitalization9.59B1.44B668%
EBITDA3.62B37B10%
Gain YTD89.152-15.672-569%
P/E Ratio30.2112.64239%
Revenue9.97B138B7%
Total Cash20.9B93.7B22%
Total Debt4.13B79.7B5%
FUNDAMENTALS RATINGS
TSMRF: Fundamental Ratings
TSMRF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
20
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HNSPFTSMRF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
50%
N/A
Momentum
ODDS (%)
Bullish Trend 7 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
22%
N/A
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
20%
Bearish Trend 4 days ago
9%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZVGIX57.911.25
+2.21%
Zevenbergen Genea Institutional
RTRIX7.410.06
+0.82%
Royce Small-Cap Total Return Instl
JORIX20.360.13
+0.64%
Janus Henderson Global Select S
MCEMX14.460.08
+0.56%
Martin Currie Emerging Markets IS
JANBX49.110.27
+0.55%
Janus Henderson Balanced D

HNSPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HNSPF has been loosely correlated with SBFM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HNSPF jumps, then SBFM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
SBFM - HNSPF
46%
Loosely correlated
-6.06%
GEDSF - HNSPF
33%
Loosely correlated
N/A
TSMRF - HNSPF
29%
Poorly correlated
N/A
ACB - HNSPF
27%
Poorly correlated
+1.57%
OGI - HNSPF
23%
Poorly correlated
+3.62%
More

TSMRF and

Correlation & Price change

A.I.dvisor tells us that TSMRF and ACB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TSMRF and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSMRF
1D Price
Change %
TSMRF100%
N/A
ACB - TSMRF
30%
Poorly correlated
+1.57%
HNSPF - TSMRF
29%
Poorly correlated
N/A
GEDSF - TSMRF
22%
Poorly correlated
N/A
TLRY - TSMRF
22%
Poorly correlated
+11.03%
CGC - TSMRF
21%
Poorly correlated
+7.56%
More